{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:15:53Z","timestamp":1791569753885,"version":"4.3.4"},"reference-count":192,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T00:00:00Z","timestamp":1660003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Central nervous system (CNS) involvement of systemic lupus erythematosus (SLE), termed neuropsychiatric SLE (NPSLE), is a major and debilitating manifestation of the disease. While patients with SLE mostly complain of common neuropsychological symptoms such headache and mild mood disorders that may not even be technically attributed to SLE, many SLE patients present with life-threatening NPSLE syndromes such as cerebrovascular disease, seizures and psychosis that are equally challenging in terms of early diagnosis and therapy. While we are just beginning to unravel some mysteries behind the immunologic basis of NPSLE, advancements in the mechanistic understanding of the complex pathogenic processes of NPSLE have been emerging through recent murine and human studies. The pathogenic pathways implicated in NPSLE are multifarious and various immune effectors such as cell-mediated inflammation, autoantibodies and cytokines including type I interferons have been found to act in concert with the disruption of the blood-brain barrier (BBB) and other neurovascular interfaces. Beyond antimicrobial functions, neutrophils are emerging as decision-shapers during innate and adaptive immune responses. Activated neutrophils have been recognized to be involved in ischemic and infective processes in the CNS by releasing neutrophil extracellular traps (NETs), matrix metalloproteinase-9 and proinflammatory cytokines. In the context of NPSLE, these mechanisms contribute to BBB disruption, neuroinflammation and externalization of modified proteins on NETs that serve as autoantigens. Neutrophils that sediment within the peripheral blood mononuclear cell fraction after density centrifugation of blood are generally defined as low-density neutrophils (LDNs) or low-density granulocytes. LDNs are a proinflammatory subset of neutrophils that are increased with SLE disease activity and are primed to undergo NETosis and release cytokines such as interferon-\u03b1 and tumor necrosis factor. This review discusses the immunopathogenesis of NPSLE with a focus on neutrophils as a core mediator of the disease and potential target for translational research in NPSLE.<\/jats:p>","DOI":"10.3389\/fimmu.2022.957303","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T04:14:16Z","timestamp":1660018456000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Insights into the role of neutrophils in neuropsychiatric systemic lupus erythematosus: Current understanding and future directions"],"prefix":"10.3389","volume":"13","author":[{"given":"Tao Ming","family":"Sim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anselm","family":"Mak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen Hee","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"16039","DOI":"10.1038\/nrdp.2016.39","article-title":"Systemic lupus erythematosus","volume":"2","author":"Kaul","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2011.11.002","article-title":"Global trend of survival and damage of systemic lupus erythematosus: Meta-analysis and meta-regression of observational studies from the 1950s to 2000s","author":"Mak","year":"2012","journal-title":"Semin Arthritis rheumatism WB Saunders"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa404","article-title":"The management of neuropsychiatric lupus in the 21st century: still so many unmet needs","volume":"59","author":"Govoni","year":"2020","journal-title":"Rheumatology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2010.62","article-title":"Pathogenesis, diagnosis and management of neuropsychiatric SLE manifestations","volume":"6","author":"Bertsias","year":"2010","journal-title":"Nat Rev Rheumatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.106351","article-title":"Prospective analysis of neuropsychiatric events in an international disease inception cohort of patients with systemic lupus erythematosus","volume":"69","author":"Hanly","year":"2010","journal-title":"Ann rheumatic Dis"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1177\/0961203313512540","article-title":"Mortality in neuropsychiatric systemic lupus erythematosus (NPSLE)","volume":"23","author":"Zirkzee","year":"2014","journal-title":"Lupus"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1177\/0961203317694261","article-title":"From animal model to human","volume":"26","author":"Pikman","year":"2017","journal-title":"Lupus"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-021-00312-0","article-title":"Cognitive dysfunction in systemic lupus erythematosus: Immunopathology, clinical manifestations, neuroimaging and management","volume":"8","author":"Seet","year":"2021","journal-title":"Rheumatol Ther"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2012.10.004","article-title":"The pathogenesis of systemic lupus erythematosus\u2013an update","volume":"24","author":"Choi","year":"2012","journal-title":"Curr Opin Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathol-020712-164023","article-title":"The multifaceted functions of neutrophils","volume":"9","author":"Mayadas","year":"2014","journal-title":"Annu Rev Pathology: Mech Dis"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.04.027","article-title":"(s) wets the whistle for neutrophil recruitment","volume":"48","author":"Watts","year":"2018","journal-title":"Immunity"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2011.132","article-title":"Neutrophils in the pathogenesis and manifestations of SLE","volume":"7","author":"Kaplan","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar4325","article-title":"Role of neutrophils in systemic autoimmune diseases","volume":"15","author":"Kaplan","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02734","article-title":"Neutrophils\u2013important communicators in systemic lupus erythematosus and antiphospholipid syndrome","volume":"10","author":"Wirestam","year":"2019","journal-title":"Front Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/art.40591","article-title":"Nervous system disease in systemic lupus erythematosus: Current status and future directions","volume":"71","author":"Hanly","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-5876-11-107","article-title":"Evaluating glymphatic pathway function utilizing clinically relevant intrathecal infusion of CSF tracer","volume":"11","author":"Yang","year":"2013","journal-title":"J Trans Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3666","article-title":"The movers and shapers in immune privilege of the CNS","volume":"18","author":"Engelhardt","year":"2017","journal-title":"Nat Immunol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780280710","article-title":"Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus","volume":"28","author":"How","year":"1985","journal-title":"Arthritis Rheumatism: Off J Am Coll Rheumatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780291105","article-title":"Low density neutrophils in patients with systemic lupus erythematosus, rheumatoid arthritis, and acute rheumatic fever","volume":"29","author":"Hacbarth","year":"1986","journal-title":"Arthritis Rheumatism"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-013-0375-7","article-title":"Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity","author":"Carmona-Rivera","year":"2013","journal-title":"Semin immunopathology Springer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20021553","article-title":"Interferon and granulopoiesis signatures in systemic lupus erythematosus blood","volume":"197","author":"Bennett","year":"2003","journal-title":"J Exp Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.1002\/art.23961","article-title":"Gene expression in human lupus: bone marrow differentiates active from inactive patients and displays apoptosis and granulopoiesis signatures","volume":"58","author":"Nakou","year":"2008","journal-title":"Arthritis rheumatism"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0902199","article-title":"A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs","volume":"184","author":"Denny","year":"2010","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1100450","article-title":"Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus","volume":"187","author":"Villanueva","year":"2011","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2016.01.001","article-title":"IL-17 in chronic inflammation: From discovery to targeting","volume":"22","author":"Beringer","year":"2016","journal-title":"Trends Mol Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4027","article-title":"Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease","volume":"22","author":"Lood","year":"2016","journal-title":"Nat Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/art.41128","article-title":"Improved mitochondrial metabolism and reduced inflammation following attenuation of murine lupus with coenzyme Q10 analog idebenone","volume":"72","author":"Blanco","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1084\/jem.20151876","article-title":"Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus","volume":"213","author":"Caielli","year":"2016","journal-title":"J Exp Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/s41584-022-00770-y","article-title":"Endothelial function and endothelial progenitor cells in systemic lupus erythematosus","volume":"18","author":"Mak","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214620","article-title":"Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus","volume":"78","author":"Rahman","year":"2019","journal-title":"Ann rheumatic Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.3390\/ijms23052505","article-title":"Type I interferons in systemic lupus erythematosus: A journey from bench to bedside","volume":"23","author":"Sim","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc Natl Acad Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V75.1.17.17","article-title":"Granulocyte colony-stimulating factor stimulates human mature neutrophilic granulocytes to produce interferon-\u03b1","volume":"75","author":"Shirafuji","year":"1990","journal-title":"Blood"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.9.6563","article-title":"Activation of an immunoregulatory and antiviral gene expression program in poly (I: C)-transfected human neutrophils","volume":"181","author":"Tamassia","year":"2008","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/art.30161","article-title":"How does IFN-\u03b1 insult the vasculature? let me count the ways","volume":"63","author":"Kaplan","year":"2011","journal-title":"Arthritis rheumatism"},{"key":"B38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.33696\/immunology.1.008","article-title":"The role of NETosis in systemic lupus erythematosus","volume":"1","author":"Salemme","year":"2019","journal-title":"J Cell Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI105479","article-title":"Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus","volume":"45","author":"Tan","year":"1966","journal-title":"J Clin Invest"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0909927107","article-title":"Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis","volume":"107","author":"Hakkim","year":"2010","journal-title":"Proc Natl Acad Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102404","article-title":"Neutrophil extracellular traps that are not degraded in systemic lupus erythematosus activate complement exacerbating the disease","volume":"188","author":"Leffler","year":"2012","journal-title":"J Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001201","article-title":"Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus","volume":"3","author":"Garcia-Romo","year":"2011","journal-title":"Sci Trans Med"},{"key":"B43","doi-asserted-by":"publisher","first-page":"73ra19","DOI":"10.1126\/scitranslmed.3001180","article-title":"Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus","volume":"3","author":"Lande","year":"2011","journal-title":"Sci Transl Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2006.08.010","article-title":"Type I interferon in systemic lupus erythematosus and other autoimmune diseases","volume":"25","author":"Banchereau","year":"2006","journal-title":"Immunity"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00081","article-title":"Neutrophil extracellular traps and its implications in inflammation: An overview","volume":"8","author":"Delgado-Rizo","year":"2017","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000639","article-title":"Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against candida albicans","volume":"5","author":"Urban","year":"2009","journal-title":"PloS Pathog"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.117.309002","article-title":"Neutrophil extracellular traps drive endothelial-to-mesenchymal transition","volume":"37","author":"Pieterse","year":"2017","journal-title":"Arteriosclerosis thrombosis Vasc Biol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.08.006","article-title":"Release of extracellular DNA influences renal ischemia reperfusion injury by platelet activation and formation of neutrophil extracellular traps","volume":"91","author":"Jansen","year":"2017","journal-title":"Kidney Int"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3913","article-title":"Neutrophils promote alzheimer's disease\u2013like pathology and cognitive decline via LFA-1 integrin","volume":"21","author":"Zenaro","year":"2015","journal-title":"Nat Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00211","article-title":"NETosis in alzheimer's disease","volume":"8","author":"Pietronigro","year":"2017","journal-title":"Front Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/febs.14075","article-title":"Neutrophil extracellular traps can serve as platforms for processing and activation of IL-1 family cytokines","volume":"284","author":"Clancy","year":"2017","journal-title":"FEBS J"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/art.39938","article-title":"In vivo role of neutrophil extracellular traps in antiphospholipid antibody\u2013mediated venous thrombosis","volume":"69","author":"Meng","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R800069200","article-title":"Catalytic domain architecture of metzincin metalloproteases","volume":"284","author":"Gomis-R\u00fcth","year":"2009","journal-title":"J Biol Chem"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2015.00019","article-title":"Multifaceted role of matrix metalloproteinases (MMPs)","volume":"2","author":"Singh","year":"2015","journal-title":"Front Mol Biosci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1183\/09031936.00146510","article-title":"Biological role of matrix metalloproteinases: a critical balance","volume":"38","author":"L\u00f6ffek","year":"2011","journal-title":"Eur Respir J"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry","volume":"92","author":"Visse","year":"2003","journal-title":"Circ Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/bs.pmbts.2017.04.003","article-title":"Matrix metalloproteinase inhibitors as investigational and therapeutic tools in unrestrained tissue remodeling and pathological disorders","volume":"148","author":"Liu","year":"2017","journal-title":"Prog Mol Biol Trans Sci"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7369020","article-title":"Matrix metalloproteinase 9 in epilepsy: The role of neuroinflammation in seizure development","volume":"2016","author":"Bronisz","year":"2016","journal-title":"Mediators Inflammation"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-3077-z","article-title":"Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer","volume":"36","author":"Liu","year":"2015","journal-title":"Tumor Biol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1152\/physiol.00029.2013","article-title":"Matrix metalloproteinase-9: Many shades of function in cardiovascular disease","volume":"28","author":"Yabluchanskiy","year":"2013","journal-title":"Physiology"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0b013e31820d94a5","article-title":"Neutrophil depletion reduces blood-brain barrier breakdown, axon injury, and inflammation after intracerebral hemorrhage","volume":"70","author":"Moxon-Emre","year":"2011","journal-title":"J Neuropathology Exp Neurol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1327.2001.02066.x","article-title":"The human neutrophil lipocalin supports the allosteric activation of matrix metalloproteinases","volume":"268","author":"Tschesche","year":"2001","journal-title":"Eur J Biochem"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1155\/MI\/2006\/17898","article-title":"Circulating total and active metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in patients with systemic lupus erythomatosus","volume":"2006","author":"Robak","year":"2006","journal-title":"Mediators Inflammation"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1002\/art.20045","article-title":"Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities","volume":"50","author":"Ainiala","year":"2004","journal-title":"Arthritis Rheumatism"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1177\/0961203309356455","article-title":"Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus","volume":"19","author":"Lesiak","year":"2010","journal-title":"Lupus"},{"key":"B66","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1177\/0961203314559085","article-title":"Matrix metalloproteinase 9 polymorphisms and systemic lupus erythematosus: correlation with systemic inflammatory markers and oxidative stress","volume":"24","author":"Bahrehmand","year":"2015","journal-title":"Lupus"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1002\/art.24603","article-title":"Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus","volume":"60","author":"Kwieci\u0144ski","year":"2009","journal-title":"Arthritis Rheumatism"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar1228","article-title":"Intrathecal levels of matrix metalloproteinases in systemic lupus erythematosus with central nervous system engagement","volume":"6","author":"Trysberg","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1177\/096120339200100209","article-title":"Interleukin-1 and interleukin-6 activities are increased in the cerebrospinal fluid of patients with CNS lupus erythematosus and correlate with local late T-cell activation markers","volume":"1","author":"Alcocer-Varela","year":"1992","journal-title":"Lupus"},{"key":"B70","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1177\/096120330000900704","article-title":"Intrathecal cytokines in systemic lupus erythematosus with central nervous system involvement","volume":"9","author":"Trysberg","year":"2000","journal-title":"Lupus"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301906","article-title":"IL-6-mediated induction of matrix metalloproteinase-9 is modulated by JAK-dependent IL-10 expression in macrophages","volume":"192","author":"Kothari","year":"2014","journal-title":"J Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(90)91190-4","article-title":"Induction and stimulation of 92-kDa gelatinase\/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor \u03b1","volume":"171","author":"Okada","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)52202-X","article-title":"Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1\/erythroid potentiating activity (TIMP-1\/EPA)","volume":"266","author":"Lotz","year":"1991","journal-title":"J Biol Chem"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1002\/art.11279","article-title":"Neuronal and astrocytic damage in systemic lupus erythematosus patients with central nervous system involvement","volume":"48","author":"Trysberg","year":"2003","journal-title":"Arthritis Rheumatism"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar1040","article-title":"Decreased levels of soluble amyloid \u03b2-protein precursor and \u03b2-amyloid protein in cerebrospinal fluid of patients with systemic lupus erythematosus","volume":"6","author":"Trysberg","year":"2004","journal-title":"Arthritis Res Ther"},{"key":"B76","first-page":"1427","article-title":"Macrophages contain 92-kd gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritis","volume":"149","author":"Nikkari","year":"1996","journal-title":"Am J Pathol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-199605000-00002","article-title":"Proteolytic cascade enzymes increase in focal cerebral ischemia in rat","volume":"16","author":"Rosenberg","year":"1996","journal-title":"J Cereb Blood Flow Metab"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.21-19-07724.2001","article-title":"Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia","volume":"21","author":"Asahi","year":"2001","journal-title":"J Neurosci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1126\/science.1073634","article-title":"S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death","volume":"297","author":"Gu","year":"2002","journal-title":"Science"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000088062.86084.F2","article-title":"Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies","volume":"34","author":"Horstmann","year":"2003","journal-title":"Stroke"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1563-05.2005","article-title":"A highly specific inhibitor of matrix metalloproteinase-9 rescues laminin from proteolysis and neurons from apoptosis in transient focal cerebral ischemia","volume":"25","author":"Gu","year":"2005","journal-title":"J Neurosci"},{"key":"B82","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/00365510802150158","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL): a new marker of kidney disease","volume":"241","author":"Devarajan","year":"2008","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"B83","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1586\/epr.12.70","article-title":"Glia-based biomarkers and their functional role in the CNS","volume":"10","author":"Jha","year":"2013","journal-title":"Expert Rev Proteomics"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2014-000038","article-title":"Blood-based candidate biomarkers of the presence of neuropsychiatric systemic lupus erythematosus in children","volume":"1","author":"Brunner","year":"2014","journal-title":"Lupus Sci Med"},{"key":"B85","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaut.2018.08.005","article-title":"Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupus","volume":"96","author":"Mike","year":"2019","journal-title":"J Autoimmun"},{"key":"B86","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1600-065X.2012.01137.x","article-title":"A model for lupus brain disease","volume":"248","author":"Diamond","year":"2012","journal-title":"Immunol Rev"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1007\/s11604-020-00989-3","article-title":"Comprehensive review of wernicke encephalopathy: pathophysiology, clinical symptoms and imaging findings","volume":"38","author":"Ota","year":"2020","journal-title":"Japanese J Radiol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"6070","DOI":"10.3390\/ijms21176070","article-title":"Nanoparticle-based technology approaches to the management of neurological disorders","volume":"21","author":"Sim","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.3727\/000000007783464731","article-title":"Blood\u2013brain barrier pathology in alzheimer's and parkinson's disease: implications for drug therapy","volume":"16","author":"Desai","year":"2007","journal-title":"Cell Transplant"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1177\/147323001204000427","article-title":"Blood\u2013brain barrier disruption is more severe in neuromyelitis optica than in multiple sclerosis and correlates with clinical disability","volume":"40","author":"Tomizawa","year":"2012","journal-title":"J Int Med Res"},{"key":"B91","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1093\/rheumatology\/kew341","article-title":"Brain histopathology in patients with systemic lupus erythematosus: identification of lesions associated with clinical neuropsychiatric lupus syndromes and the role of complement","volume":"56","author":"Cohen","year":"2017","journal-title":"Rheumatology"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.026542","article-title":"Cerebral vasculitis as a primary manifestation of systemic lupus erythematosus","volume":"64","author":"Rowshani","year":"2005","journal-title":"Ann rheumatic Dis"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(83)91075-6","article-title":"Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction","volume":"74","author":"Winfield","year":"1983","journal-title":"Am J Med"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-018-0156-8","article-title":"Neuropsychiatric lupus: new mechanistic insights and future treatment directions","volume":"15","author":"Schwartz","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jaut.2015.03.005","article-title":"TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL\/lpr mice","volume":"60","author":"Wen","year":"2015","journal-title":"J Autoimmun"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1016\/j.dadm.2017.04.007","article-title":"Consensus guidelines for lumbar puncture in patients with neurological diseases","volume":"8","author":"Engelborghs","year":"2017","journal-title":"Alzheimer's Dementia: Diagnosis Assess Dis Monit"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1023\/A:1015147920283","article-title":"Frequent blood\u2013brain barrier disruption in the human cerebral cortex","volume":"21","author":"Tomkins","year":"2001","journal-title":"Cell Mol Neurobiol"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2015.05.002","article-title":"A multimodal MRI approach to identify and characterize microstructural brain changes in neuropsychiatric systemic lupus erythematosus","volume":"8","author":"Ercan","year":"2015","journal-title":"NeuroImage Clin"},{"key":"B99","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/acr.22923","article-title":"Altered blood-brain barrier permeability in patients with systemic lupus erythematosus: A novel imaging approach","volume":"69","author":"Gulati","year":"2017","journal-title":"Arthritis Care Res"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A5990","article-title":"Alterations in blood-brain barrier permeability in patients with systemic lupus erythematosus","volume":"40","author":"Chi","year":"2019","journal-title":"AJNR Am J neuroradiology"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218004","article-title":"Blood-brain barrier leakage in systemic lupus erythematosus is associated with gray matter loss and cognitive impairment","volume":"79","author":"Kamintsky","year":"2020","journal-title":"Ann rheumatic Dis"},{"key":"B102","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1002\/acr.22923","article-title":"Altered blood\u2013brain barrier permeability in patients with systemic lupus erythematosus: a novel imaging approach","volume":"69","author":"Gulati","year":"2017","journal-title":"Arthritis Care Res"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.852835","article-title":"Increasing of blood brain barrier permeability and the association with depression and anxiety in systemic lupus erythematosus patients","volume":"9","author":"Wang","year":"2022","journal-title":"Front Med"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.107.500868","article-title":"MMP-9\u2013positive neutrophil infiltration is associated to blood\u2013brain barrier breakdown and basal lamina type iv collagen degradation during hemorrhagic transformation after human ischemic stroke","volume":"39","author":"Rosell","year":"2008","journal-title":"Stroke"},{"key":"B105","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1191\/135248506ms1274oa","article-title":"Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis","volume":"12","author":"Fainardi","year":"2006","journal-title":"Multiple Sclerosis J"},{"key":"B106","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jneuroim.2012.07.011","article-title":"Adhesion molecule expression precedes brain damages of lupus-prone mice and correlates with kidney pathology","volume":"252","author":"Stielke","year":"2012","journal-title":"J Neuroimmunology"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1300858","article-title":"\u03b22 integrin\u2013mediated crawling on endothelial ICAM-1 and ICAM-2 is a prerequisite for transcellular neutrophil diapedesis across the inflamed blood\u2013brain barrier","volume":"192","author":"Gorina","year":"2014","journal-title":"J Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780280810","article-title":"The value of complement and immune complex determinations in monitoring disease activity in patients with systemic lupus erythematosus","volume":"28","author":"Valentijn","year":"1985","journal-title":"Arthritis Rheumatism"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.624025","article-title":"Complement receptors and their role in leukocyte recruitment and phagocytosis","volume":"9","author":"Vandendriessche","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41423-018-0024-0","article-title":"NETosis, complement, and coagulation: a triangular relationship","volume":"16","author":"de Bont","year":"2019","journal-title":"Cell Mol Immunol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1111\/jre.12284","article-title":"Influence of complement on neutrophil extracellular trap release induced by bacteria","volume":"51","author":"Palmer","year":"2016","journal-title":"J periodontal Res"},{"key":"B112","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000206974","article-title":"Regulation of extracellular chromatin release from neutrophils","volume":"1","author":"Neeli","year":"2009","journal-title":"J innate Immun"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200636638","article-title":"Absence of functional alternative complement pathway alleviates lupus cerebritis","volume":"37","author":"Alexander","year":"2007","journal-title":"Eur J Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1007\/s12017-009-8085-y","article-title":"The role of the complement system and the activation fragment C5a in the central nervous system","volume":"12","author":"Woodruff","year":"2010","journal-title":"Neuromolecular Med"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.9.5702","article-title":"Effects of complement C5 on apoptosis in experimental autoimmune encephalomyelitis","volume":"172","author":"Niculescu","year":"2004","journal-title":"J Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901005","article-title":"Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of alzheimer\u2019s disease","volume":"183","author":"Fonseca","year":"2009","journal-title":"J Immunol"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1002\/1097-4652(200011)185:2<280::AID-JCP13>3.0.CO;2-L","article-title":"A new apoptotic pathway for the complement factor b-derived fragment bb","volume":"185","author":"Uwai","year":"2000","journal-title":"J Cell Physiol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1096\/fj.09-138834","article-title":"C5a alters blood-brain barrier integrity in experimental lupus","volume":"24","author":"Jacob","year":"2010","journal-title":"FASEB J"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.2011.07490.x","article-title":"C5a\/CD88 signaling alters blood\u2013brain barrier integrity in lupus through nuclear factor-\u03baB","volume":"119","author":"Jacob","year":"2011","journal-title":"J neurochemistry"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12489","article-title":"C5a alters blood\u2013brain barrier integrity in a human in vitro model of systemic lupus erythematosus","volume":"146","author":"Mahajan","year":"2015","journal-title":"Immunology"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2004.03.004","article-title":"Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus","volume":"41","author":"Arora","year":"2004","journal-title":"Mol Immunol"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20180776","article-title":"Lupus antibodies induce behavioral changes mediated by microglia and blocked by ACE inhibitors","volume":"215","author":"Nestor","year":"2018","journal-title":"J Exp Med"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-008-0921-1","article-title":"Association of anti-ribosomal p protein antibodies with neuropsychiatric and other manifestations of systemic lupus erythematosus","volume":"27","author":"Abdel-Nasser","year":"2008","journal-title":"Clin Rheumatol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000058904.94330.A7","article-title":"Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies","volume":"61","author":"Afeltra","year":"2003","journal-title":"Neurology"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1002\/art.30616","article-title":"NR2-reactive antibody decreases cell viability through augmentation of Ca2+ influx in systemic lupus erythematosus","volume":"63","author":"Gono","year":"2011","journal-title":"Arthritis Rheumatism"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-08-044669","article-title":"Antiendothelial cell antibodies mediate enhanced leukocyte adhesion to cytokine-activated endothelial cells through a novel mechanism requiring cooperation between Fc\u03b3RIIa and CXCR1\/2","volume":"109","author":"Florey","year":"2007","journal-title":"Blood"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.15","article-title":"Diagnosis and management of neuropsychiatric SLE","volume":"10","author":"Hanly","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2015.00473","article-title":"NMDA receptor function during senescence: implication on cognitive performance","volume":"9","author":"Kumar","year":"2015","journal-title":"Front Neurosci"},{"key":"B129","article-title":"The pathogenesis of neuropsychiatric manifestations in systemic lupus erythematosus: a disease in search of autoantibodies, or autoantibodies in search of a disease","volume":"31","author":"Sen\u00e9cal","year":"2004","journal-title":"J Rheumatol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1002\/art.37745","article-title":"IgG anti\u2013NR2 glutamate receptor autoantibodies from patients with systemic lupus erythematosus activate endothelial cells","volume":"65","author":"Yoshio","year":"2013","journal-title":"Arthritis Rheumatism"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1038\/nm1101-1189","article-title":"A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus","volume":"7","author":"DeGiorgio","year":"2001","journal-title":"Nat Med"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0608397104","article-title":"Human lupus autoantibodies against NMDA receptors mediate cognitive impairment","volume":"103","author":"Kowal","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1134\/S0006297911040109","article-title":"Effect of homocysteine on properties of neutrophils activated in vivo","volume":"76","author":"Bryushkova","year":"2011","journal-title":"Biochem (Mosc)"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2004.00976.x","article-title":"Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors","volume":"12","author":"Omdal","year":"2005","journal-title":"Eur J Neurol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314555538","article-title":"Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus","volume":"24","author":"Massardo","year":"2015","journal-title":"Lupus"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1002\/art.23399","article-title":"Association of cerebrospinal fluid anti\u2013NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus","volume":"58","author":"Arinuma","year":"2008","journal-title":"Arthritis Rheumatism"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar4518","article-title":"Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric\/neuropsychological syndromes in systemic lupus erythematosus","volume":"16","author":"Hirohata","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"B138","article-title":"Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus","volume":"33","author":"Hanly","year":"2006","journal-title":"J Rheumatol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1002\/art.21547","article-title":"Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus","volume":"54","author":"Yoshio","year":"2006","journal-title":"Arthritis Rheumatism"},{"key":"B140","doi-asserted-by":"publisher","first-page":"e000785","DOI":"10.1136\/rmdopen-2018-000785","article-title":"Antiphospholipid syndrome: state of the art on clinical practice guidelines","volume":"4","author":"Limper","year":"2018","journal-title":"RMD Open"},{"key":"B141","doi-asserted-by":"publisher","first-page":"75","DOI":"10.5152\/eurjrheum.2015.0085","article-title":"The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus","volume":"3","author":"\u00dcnl\u00fc","year":"2016","journal-title":"Eur J Rheumatol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.103","article-title":"Antiphospholipid syndrome","volume":"4","author":"Schreiber","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199904)42:4<728::AID-ANR16>3.0.CO;2-O","article-title":"A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus","volume":"42","author":"Hanly","year":"1999","journal-title":"Arthritis Rheumatism"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199904)42:4<735::AID-ANR17>3.0.CO;2-L","article-title":"A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus","volume":"42","author":"Menon","year":"1999","journal-title":"Arthritis Rheumatism"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0196103","article-title":"Cognitive dysfunction improves in systemic lupus erythematosus: results of a 10 years prospective study","volume":"13","author":"Ceccarelli","year":"2018","journal-title":"PloS One"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.10.003","article-title":"A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus","volume":"15","author":"Ho","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh384","article-title":"Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort","volume":"43","author":"Mikdashi","year":"2004","journal-title":"Rheumatology"},{"key":"B148","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/0961203310382429","article-title":"The endothelium: an interface between autoimmunity and atherosclerosis in systemic lupus erythematosus","volume":"20","author":"Narshi","year":"2011","journal-title":"Lupus"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.077594","article-title":"Seizures in patients with systemic lupus erythematosus: data from LUMINA, a multiethnic cohort (LUMINA LIV)","volume":"67","author":"Andrade","year":"2008","journal-title":"Ann rheumatic Dis"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(21)00209-X","article-title":"Neurologic complications of antiphospholipid antibodies","volume":"19","author":"Brey","year":"1993","journal-title":"Rheumatic Dis Clinics North America"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2014.04.003","article-title":"Antibody-specific behavioral effects: intracerebroventricular injection of antiphospholipid antibodies induces hyperactive behavior while anti-ribosomal-P antibodies induces depression and smell deficits in mice","volume":"272","author":"Katzav","year":"2014","journal-title":"J Neuroimmunology"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2012.03.011","article-title":"Neuropsychiatric lupus: the prevalence and autoantibody associations depend on the definition: results from the 1000 faces of lupus cohort","author":"Borowoy","year":"2012","journal-title":"Semin Arthritis rheumatism Elsevier"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-008-9902-7","article-title":"Effects of exogenous excitatory amino acid neurotransmitters on blood\u2013brain barrier disruption in focal cerebral ischemia","volume":"34","author":"Chi","year":"2009","journal-title":"Neurochemical Res"},{"key":"B154","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1002\/art.39247","article-title":"Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: a newly identified mechanism of thrombosis in the antiphospholipid syndrome","volume":"67","author":"Yalavarthi","year":"2015","journal-title":"Arthritis Rheumatol (Hoboken N.J.)"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1016\/S1607-551X(08)70121-9","article-title":"Tumor-like cerebral perivasculitis in a pediatric patient with systemic lupus erythematosus","volume":"24","author":"Huang","year":"2008","journal-title":"Kaohsiung J Med Sci"},{"key":"B156","article-title":"Marked cerebrospinal fluid pleocytosis in systemic lupus erythematosus related cerebral ischemia","volume":"19","author":"Abialmouna","year":"1992","journal-title":"J Rheumatol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1177\/0961203307081846","article-title":"Marked inflammation in catastrophic longitudinal myelitis associated with systemic lupus erythematosus","volume":"16","author":"Heinlein","year":"2007","journal-title":"Lupus"},{"key":"B158","article-title":"A case of systemic lupus erythematosus associated with longitudinal extensive transverse myelitis, cerebral neutrophilic vasculitis, and cerebritis","volume":"72","author":"Modjinou","year":"2014","journal-title":"Bull Hosp Joint Dis"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1002\/art.24937","article-title":"Distinct subtypes of myelitis in systemic lupus erythematosus","volume":"60","author":"Birnbaum","year":"2009","journal-title":"Arthritis rheumatism"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310508","article-title":"Increased levels of plasma anaphylatoxins in systemic lupus erythematosus predict flares of the disease and may elicit vascular injury in lupus cerebritis","volume":"31","author":"Hopkins","year":"1988","journal-title":"Arthritis Rheumatism"},{"key":"B161","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jneuroim.2010.02.011","article-title":"Inhibition of C5a receptor alleviates experimental CNS lupus","volume":"221","author":"Jacob","year":"2010","journal-title":"J neuroimmunology"},{"key":"B162","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0303-8467(92)90117-L","article-title":"Purulent meningitis due to aspergillosis in a patient with systemic lupus erythematosus","volume":"94","author":"Lammens","year":"1992","journal-title":"Clin Neurol Neurosurg"},{"key":"B163","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4103\/0028-3886.173662","article-title":"Fatal granulomatous amoebic encephalitis caused by acanthamoeba in a newly diagnosed patient with systemic lupus erythematosus","volume":"64","author":"Thamtam","year":"2016","journal-title":"Neurol India"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-229537","article-title":"West Nile Encephalitis mimicking neuropsychiatric lupus in a patient with systemic lupus erythematosus","volume":"12","author":"Iyer","year":"2019","journal-title":"BMJ Case Rep CP"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.11.1185","article-title":"The challenge of drug-induced aseptic meningitis","volume":"159","author":"Moris","year":"1999","journal-title":"Arch Internal Med"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex018","article-title":"Diagnosing and attributing neuropsychiatric events to systemic lupus erythematosus: time to untie the Gordian knot","volume":"56","author":"Tay","year":"2017","journal-title":"Rheumatology"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.61.1.104","article-title":"Factors predictive of corticosteroid psychosis in patients with systemic lupus erythematosus","volume":"61","author":"Chau","year":"2003","journal-title":"Neurology"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780260509","article-title":"Neutrophil aggregation induced by sera from patients with active systemic lupus erythematosus","volume":"26","author":"Abramson","year":"1983","journal-title":"Arthritis Rheumatism"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/9931742","article-title":"The role of neutrophil extracellular traps in central nervous system diseases and prospects for clinical application","volume":"2021","author":"Guo","year":"2021","journal-title":"Oxid Med Cell Longevity"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1080\/08916934.2018.1514496","article-title":"Active NET formation in libman\u2013sacks endocarditis without antiphospholipid antibodies: a dramatic onset of systemic lupus erythematosus","volume":"51","author":"Appelgren","year":"2018","journal-title":"Autoimmunity"},{"key":"B171","article-title":"Inhibition of neutrophil elastase protects against glomerulonephritis and thrombosis in a mouse model of lupus","volume":"69","author":"Sule","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1172\/JCI67390","article-title":"Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus","volume":"123","author":"Knight","year":"2013","journal-title":"J Clin Invest"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.2174\/1389450116666150202160954","article-title":"Protein arginine deiminases and associated citrullination: physiological functions and diseases associated with dysregulation","volume":"16","author":"Witalison","year":"2015","journal-title":"Curr Drug Targets"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1001620","article-title":"N-\u03b1-benzoyl-N5-(2-chloro-1-iminoethyl)-L-ornithine amide, a protein arginine deiminase inhibitor, reduces the severity of murine collagen-induced arthritis","volume":"186","author":"Willis","year":"2011","journal-title":"J Immunol"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12932","article-title":"Protein arginine deiminase 4 inhibition is sufficient for the amelioration of collagen-induced arthritis","volume":"188","author":"Willis","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"B176","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep26430","article-title":"Abrogation of collagen-induced arthritis by a peptidyl arginine deiminase inhibitor is associated with modulation of T cell-mediated immune responses","volume":"6","author":"Kawalkowska","year":"2016","journal-title":"Sci Rep"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-020-0409-1","article-title":"PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets","volume":"16","author":"Curran","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100239","article-title":"PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps","volume":"207","author":"Li","year":"2010","journal-title":"J Exp Med"},{"key":"B179","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2019.02.007","article-title":"Neutrophil extracellular traps confine pseudomonas aeruginosa ocular biofilms and restrict brain invasion","volume":"25","author":"Thanabalasuriar","year":"2019","journal-title":"Cell Host Microbe"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097088","article-title":"Efficient neutrophil extracellular trap induction requires mobilization of both intracellular and extracellular calcium pools and is modulated by cyclosporine a","volume":"9","author":"Gupta","year":"2014","journal-title":"PloS One"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0b013e3283025ec2","article-title":"Tuberculosis reactivation during immunosuppressive therapy in rheumatic diseases: diagnostic and therapeutic strategies","volume":"20","author":"Keane","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevImmunol.v15.i2.10","article-title":"Complement receptors in neutrophils","volume":"15","author":"Sengelov","year":"1995","journal-title":"Crit Rev Immunol"},{"key":"B183","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the treatment of ANCA-associated vasculitis","volume":"384","author":"Jayne","year":"2021","journal-title":"New Engl J Med"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013020143","article-title":"C5a receptor (CD88) blockade protects against MPO-ANCA GN","volume":"25","author":"Xiao","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016111179","article-title":"Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis","volume":"28","author":"Jayne","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.1002\/acr2.11185","article-title":"Adjunctive treatment with avacopan, an oral C5a receptor inhibitor, in patients with antineutrophil cytoplasmic antibody\u2013associated vasculitis","volume":"2","author":"Merkel","year":"2020","journal-title":"ACR Open Rheumatol"},{"key":"B187","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164646","article-title":"Characterization of pharmacologic and pharmacokinetic properties of CCX168, a potent and selective orally administered complement 5a receptor inhibitor, based on preclinical evaluation and randomized phase 1 clinical study","volume":"11","author":"Bekker","year":"2016","journal-title":"PLoS One"},{"key":"B188","article-title":"Antiphospholipid antibodies and complement activation in patients with cerebral ischemia","volume":"10","author":"Davis","year":"1992","journal-title":"Clin Exp Rheumatol"},{"key":"B189","doi-asserted-by":"publisher","first-page":"103055","DOI":"10.1016\/j.autrev.2022.103055","article-title":"Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the \"CAPS registry\"","volume":"21","author":"L\u00f3pez-Benjume","year":"2022","journal-title":"Autoimmun Rev"},{"key":"B190","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.777932","article-title":"Human neutrophils respond to complement activation and inhibition in microfluidic devices","volume":"12","author":"Muldur","year":"2021","journal-title":"Front Immunol"},{"key":"B191","doi-asserted-by":"publisher","DOI":"10.3390\/ijms160510281","article-title":"Anti-NR2A\/B antibodies and other major molecular mechanisms in the pathogenesis of cognitive dysfunction in systemic lupus erythematosus","volume":"16","author":"Tay","year":"2015","journal-title":"Int J Mol Sci"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1002\/art.41395","article-title":"Low-density neutrophils in systemic lupus erythematosus","volume":"72","author":"Tay","year":"2020","journal-title":"Arthritis Rheumatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.957303\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T04:14:26Z","timestamp":1660018466000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.957303\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,9]]},"references-count":192,"alternative-id":["10.3389\/fimmu.2022.957303"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.957303","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,9]]},"article-number":"957303"}}